In the stratified analysis, high PLCE1 expression increased the risk of recurrence and death among patients who were male and had early-stage BCLC, who had a single tumor, cirrhosis, AFP level > 300 ng/ml (Figure 6A and 6B). The gene discussed is PLCE1; the disease is Cirrhosis.